$15.77
arrow_drop_down3.95%Key Stats | |
---|---|
Open | $16.14 |
Prev. Close | $16.43 |
EPS | -3.19 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 16.05 | 16.43 |
52 Week Range | 12.95 | 20.31 |
Ratios | |
---|---|
EPS | -3.19 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Retinoblastoma Treatment Market to Surpass $2 Billion in 2024, Exhibiting a CAGR of 5.5% - Global Long-term Forecasts to 2028 and 2033
Cracking The Code: Understanding Analyst Reviews For Arcus Biosciences - Arcus Biosciences (NYSE:RCUS) - Benzinga
Is The Options Market Predicting a Spike In Arcus Biosciences (RCUS) Stock?
Gilead (GILD), RCUS Announce Data From Colorectal Cancer Study
Wall Street Breakfast: The Week Ahead
Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Tops Revenue Estimates